Nyxoah Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.4%.

Top 25 shareholders own 78.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.1%	Cochlear Limited	5,631,319	€45.1m	0%	no data
8.44%	Gilde Healthcare Partners B.V.	3,153,822	€25.2m	0%	47.04%
8.03%	Vestal Point Capital, LP	3,000,688	€24.0m	0%	2.1%
7.86%	Anneliese Monden	2,940,258	€23.5m	0%	no data
7.85%	Gilde Healthcare Holding B.v.	2,936,890	€23.5m	0%	no data
7.55%	Robert Taub	2,823,030	€22.6m	0%	no data
4.59%	FMR LLC	1,715,125	€13.7m	0.03%	no data
4.33%	ResMed Inc.	1,619,756	€13.0m	0%	no data
3.59%	Jurgen Hambrecht	1,344,000	€10.8m	0%	no data
2.85%	BlackRock, Inc.	1,065,121	€8.5m	2.1%	no data
1.52%	Bmi Estate	567,484	€4.5m	0%	no data
1.4%	BNPP Asset Management Holding	524,890	€4.2m	0%	0.01%
0.78%	Putnam LLC	292,570	€2.3m	-0.03%	no data
0.69%	Schroder Investment Management Limited	259,608	€2.1m	0%	no data
0.5%	Millennium Management LLC	187,367	€1.5m	-8.27%	no data
0.49%	Heights Capital Management, Inc.	183,590	€1.5m	0%	0.64%
0.47%	Swedbank Robur Fonder AB	175,000	€1.4m	0%	no data
0.41%	AXA Investment Managers S.A.	152,000	€1.2m	0%	no data
0.4%	Susquehanna International Group, LLP, Asset Management Arm	149,654	€1.2m	0%	no data
0.36%	BNP Paribas Asset Management Europe	133,308	€1.1m	0%	no data
0.33%	Kevin Rakin	123,500	€988.0k	0%	no data
0.32%	Medical Strategy GmbH, Asset Management Arm	117,953	€943.6k	0%	0.06%
0.32%	Rossmore Private Capital, LLC	117,940	€943.5k	0%	0.12%
0.29%	Dafna Capital Management, LLC	108,108	€864.9k	0%	0.23%
0.21%	Candriam	76,825	€614.6k	0%	no data